Literature DB >> 19563731

Percutaneous interventions in adults with congenital heart disease: expanding indications and opportunities.

Stéphane Noble1, Réda Ibrahim.   

Abstract

Percutaneous intervention in adults with congenital heart disease has advanced rapidly in recent years and represents a growing field of invasive cardiology. Valve replacement, stent implantation for native and recurrent coarctation, and ventricular septal defect closure have emerged as attractive alternatives to surgery and have been added to the existing validated procedures (eg, atrial septum defect closure, persistent ductus arteriosus occlusion, and pulmonary valve dilatation). This review summarizes current and expanding indications for transcatheter interventions in adults with congenital heart disease.

Entities:  

Mesh：

Year:  2009        PMID： 19563731     DOI： 10.1007/s11886-009-0044-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  44 in total

Review 1.  Congenital heart disease in adults. First of two parts.

Authors:  M E Brickner; L D Hillis; R A Lange
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

2.  Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale.

Authors:  Peter Germonpre; Costantino Balestra
Journal:  Eur Heart J       Date:  2004-12       Impact factor: 29.983

Review 3.  Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions.

Authors:  Robert J Sommer; Ziyad M Hijazi; John F Rhodes
Journal:  Circulation       Date:  2008-02-26       Impact factor: 29.690

4.  Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

Authors:  V Menon; J G Webb; L D Hillis; L A Sleeper; R Abboud; V Dzavik; J N Slater; R Forman; E S Monrad; J D Talley; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

5.  Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims.

Authors:  Zhong-Dong Du; Peter Koenig; Q-Ling Cao; David Waight; Mary Heitschmidt; Ziyad M Hijazi
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

6.  Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder.

Authors:  R Dhillon; B Thanopoulos; G Tsaousis; F Triposkiadis; M Kyriakidis; A Redington
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

7.  Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder.

Authors:  Basil Vasilios D Thanopoulos; Michael L Rigby; Evangelos Karanasios; Christodoulos Stefanadis; Nico Blom; Jaap Ottenkamp; Armine Zarayelyan
Journal:  Am J Cardiol       Date:  2007-02-16       Impact factor: 2.778

8.  Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure.

Authors:  Marie-Claude Brochu; Jean-François Baril; Annie Dore; Martin Juneau; Pierre De Guise; Lise-Andrée Mercier
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

9.  Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis.

Authors:  C J Hayes; W M Gersony; D J Driscoll; J F Keane; L Kidd; W M O'Fallon; D R Pieroni; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defect.

Authors:  Elliot M Tucker; Lee A Pyles; John L Bass; James H Moller
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094
View more
  2 in total

1.  Transcatheter closure with use of the SHSMA occluder in 180 patients with congenital heart defects: preliminary results.

Authors:  Wan-Feng Sun; Zhi-Feng Dong; Kaizheng Gong; Guo-Pei Zhang; Ting Cui; Yu-Dong Xia; Jing Dong; Yuan Shen
Journal:  Tex Heart Inst J       Date:  2010

2.  Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience.

Authors:  Tugcin Bora Polat; Esma Türkmen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.